Suppr超能文献

Syndecans及其合成抑制素:靶向细胞-基质界面处受体酪氨酸激酶信号转导的组织者

Syndecans and Their Synstatins: Targeting an Organizer of Receptor Tyrosine Kinase Signaling at the Cell-Matrix Interface.

作者信息

Rapraeger Alan C

机构信息

Department of Human Oncology, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, United States.

出版信息

Front Oncol. 2021 Oct 27;11:775349. doi: 10.3389/fonc.2021.775349. eCollection 2021.

Abstract

Receptor tyrosine kinases (RTKs) and integrin matrix receptors have well-established roles in tumor cell proliferation, invasion and survival, often functioning in a coordinated fashion at sites of cell-matrix adhesion. Central to this coordination are syndecans, another class of matrix receptor, that organize RTKs and integrins into functional units, relying on docking motifs in the syndecan extracellular domains to capture and localize RTKs (e.g., EGFR, IGF-1R, VEGFR2, HER2) and integrins (e.g., αvβ3, αvβ5, α4β1, α3β1, α6β4) to sites of adhesion. Peptide mimetics of the docking motifs in the syndecans, called "synstatins", prevent assembly of these receptor complexes, block their signaling activities and are highly effective against tumor cell invasion and survival and angiogenesis. This review describes our current understanding of these four syndecan-coupled mechanisms and their inhibitory synstatins (SSTN, SSTN, SSTN, SSTN and SSTN).

摘要

受体酪氨酸激酶(RTKs)和整合素基质受体在肿瘤细胞增殖、侵袭和存活中具有已明确的作用,常在细胞-基质黏附位点以协同方式发挥功能。这种协同作用的核心是多配体蛋白聚糖,它是另一类基质受体,能将RTKs和整合素组织成功能单元,依靠多配体蛋白聚糖胞外结构域中的对接基序将RTKs(如表皮生长因子受体、胰岛素样生长因子-1受体、血管内皮生长因子受体2、人表皮生长因子受体2)和整合素(如αvβ3、αvβ5、α4β1、α3β1、α6β4)捕获并定位到黏附位点。多配体蛋白聚糖中对接基序的肽模拟物,即“整合素结合抑制肽”,可阻止这些受体复合物的组装,阻断其信号传导活性,并且对肿瘤细胞侵袭、存活及血管生成具有高效抑制作用。本综述阐述了我们目前对这四种多配体蛋白聚糖偶联机制及其抑制性整合素结合抑制肽(SSTN、SSTN、SSTN、SSTN和SSTN)的理解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8bb/8578902/68bcdfebeb8e/fonc-11-775349-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验